Regular ArticleWAF1 Genotype and Endometrial Cancer Susceptibility
References (33)
- et al.
A genetic model for colorectal tumorigenesis
Cell
(1990) - et al.
Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
Exp Cell Res
(1994) - et al.
WAF1, a potent mediator of p53 tumor suppression
Cell
(1993) - et al.
Molecular analysis of the Cip1/Waf1 (p21) gene in diverse types of human tumors
Biochim Biophys Acta
(1995) - et al.
Identification of the αIIb3
J Biol Chem
(1992) - et al.
Cloning of p27Kip1
Cell
(1994) - et al.
Chromosomal deletions and K-RAS
Int J Cancer
(1992) - et al.
Involvement of p53 gene mutations in human endometrial carcinomas
Int J Cancer
(1993) - et al.
DCC
Int J Cancer
(1994) - et al.
Allelic loss on chromosome 17p andp53
Cancer Res
(1991)
The p53 tumour suppressor gene
Nature
(1991)
p53 mutations in human cancers
Science
(1991)
The p21 Cdk-Interacting Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
Cell
(1993)
p21 is a universal inhibitor of cyclin kinases
Nature
(1993)
Somatic mutations of the WAF1/CIP1 gene in primary prostate cancer
Oncogene
(1995)
Cited by (30)
Common gene polymorphisms, cancer progression and prognosis
2004, Cancer Lettersp53 and p21 genetic polymorphisms and susceptibility to endometrial cancer
2004, Gynecologic OncologyMolecular epidemiology, biomarkers and cancer prevention
2001, Trends in Molecular MedicineCrosstalk of Cyclin-dependent kinase inhibitor 1A (CDKN1A) gene polymorphism with p53 and CCND1 polymorphism in breast cancer
2021, European Review for Medical and Pharmacological Sciences
- 1
To whom correspondence and reprint requests should be addressed. Fax: 81-977-27-1661.
Copyright © 1999 Academic Press. All rights reserved.